This compound is a pharmaceutical intermediate primarily used in the synthesis of lenacapavir. It is a complex, highly halogenated organic molecule containing multiple ring systems and functional groups, designed for research and manufacturing applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2375020-20-3
Lenacapavir
pharmaceutical raw material
Lenacapavir
pharmaceutical raw material
(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoic acid
pharmaceutical intermediate
1-Pyrrolidinecarboxylic acid, 2,2'-[[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-, 1,1'-bis(1,1-dimethylethyl) ester, (2S,2'S)-
pharmaceutical intermediate
(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylic acid
pharmaceutical intermediate
3-methanesulfonyl-3-methylbut-1-yne
pharmaceutical intermediate
(S)-3,3-difluoropiperidin-4-ol hydrochloride
pharmaceutical intermediate
Tert-butyl 2-methyl-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate
pharmaceutical intermediate
N-[(1S)-1-[3-[3-amino-4-chloro-1-(2,2,2-trifluoroethyl)indazol-7-yl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-5,5-difluoro-9-(trifluoromethyl)-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide
ISVGOULQBYJQFS-GSLIJJQTSA-N
CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)N)[C@H](CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C([C@H]7C[C@H]7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C